BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31730006)

  • 1. Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow.
    Liu D; Lv H; Liu Q; Sun Y; Hou S; Zhang L; Yang M; Han B; Wang G; Wang X; Du W; Nie H; Zhang R; Huang X; Hou J; Yu B
    J Transl Med; 2019 Nov; 17(1):378. PubMed ID: 31730006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis.
    Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway.
    Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J
    Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells.
    Xu S; Koroleva M; Yin M; Jin ZG
    Transl Res; 2016 Oct; 176():18-28.e2. PubMed ID: 27295628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminar flow inhibits the Hippo/YAP pathway via autophagy and SIRT1-mediated deacetylation against atherosclerosis.
    Yuan P; Hu Q; He X; Long Y; Song X; Wu F; He Y; Zhou X
    Cell Death Dis; 2020 Feb; 11(2):141. PubMed ID: 32081881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow.
    Wang L; Luo JY; Li B; Tian XY; Chen LJ; Huang Y; Liu J; Deng D; Lau CW; Wan S; Ai D; Mak KK; Tong KK; Kwan KM; Wang N; Chiu JJ; Zhu Y; Huang Y
    Nature; 2016 Dec; 540(7634):579-582. PubMed ID: 27926730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-α-Induced YAP/TAZ Activity Mediates Leukocyte-Endothelial Adhesion by Regulating VCAM1 Expression in Endothelial Cells.
    Choi HJ; Kim NE; Kim BM; Seo M; Heo JH
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30388809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow.
    Li B; He J; Lv H; Liu Y; Lv X; Zhang C; Zhu Y; Ai D
    J Clin Invest; 2019 Mar; 129(3):1167-1179. PubMed ID: 30629551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic nanodrug targets inflammation and suppresses YAP/TAZ to ameliorate atherosclerosis.
    Huang HC; Wang TY; Rousseau J; Orlando M; Mungaray M; Michaud C; Plaisier C; Chen ZB; Wang KC
    Biomaterials; 2024 Apr; 306():122505. PubMed ID: 38359507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harmine alleviates atherogenesis by inhibiting disturbed flow-mediated endothelial activation via protein tyrosine phosphatase PTPN14 and YAP.
    Yang Y; Ma Q; Li Z; Wang H; Zhang C; Liu Y; Li B; Wang Y; Cui Q; Xue F; Ai D; Zhu Y; He J
    Br J Pharmacol; 2021 Apr; 178(7):1524-1540. PubMed ID: 33474722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis.
    Toyama T; Looney AP; Baker BM; Stawski L; Haines P; Simms R; Szymaniak AD; Varelas X; Trojanowska M
    J Invest Dermatol; 2018 Jan; 138(1):78-88. PubMed ID: 28870693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Intensity Pulsed Ultrasound Treatment Accelerates Angiogenesis by Activating YAP/TAZ in Human Umbilical Vein Endothelial Cells.
    Xu XM; Xu TM; Wei YB; Gao XX; Sun JC; Wang Y; Kong QJ; Shi JG
    Ultrasound Med Biol; 2018 Dec; 44(12):2655-2661. PubMed ID: 30205992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvianolic acid B ameliorates atherosclerosis via inhibiting YAP/TAZ/JNK signaling pathway in endothelial cells and pericytes.
    Yang Y; Pei K; Zhang Q; Wang D; Feng H; Du Z; Zhang C; Gao Z; Yang W; Wu J; Li Y
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158779. PubMed ID: 32739616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.
    Liu C; Cheng X; Chen J; Wang Y; Wu X; Tian R; Liu B; Ding X; Sun Q; Gong W
    Theranostics; 2019; 9(13):3840-3852. PubMed ID: 31281517
    [No Abstract]   [Full Text] [Related]  

  • 18. Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation.
    Jia M; Li Q; Guo J; Shi W; Zhu L; Huang Y; Li Y; Wang L; Ma S; Zhuang T; Wang X; Pan Q; Wei X; Qin Y; Li X; Jin J; Zhi X; Tang J; Jing Q; Li S; Jiang L; Qu L; Osto E; Zhang J; Wang X; Yu B; Meng D
    Circ Res; 2022 Apr; 130(7):1038-1055. PubMed ID: 35196865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.